Opening book details…
About this Biochemistry, Genetics and Molecular Biology article
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07 by von Moos, Roger is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- von Moos, Roger
- Publisher
- Spandidos Publications Ltd; Spandidos Publications; Demetrios A. Spandidos Ed. & Pub. (ISSN 1021-335X)
- Published
- 2012
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)